Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Sili'an Pharmaceutical is a leading Chinese pharmaceutical company specializing in maternal and child health, nutrition, and cardiovascular medicine. The company is globally recognized for its Sili'an brand of 0.4mg folic acid tablets, which were developed through a landmark Sino-US research collaboration to prevent neural tube defects. Beyond its core folic acid products, the company offers a diverse portfolio including multivitamins, probiotics, and treatments for H-type hypertension. Sili'an operates advanced GMP-certified manufacturing facilities in Beijing and maintains a dominant market position in the Chinese prenatal supplement sector. The company continues to invest in R&D to expand its offerings in chronic disease management and preventive healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Sili'an Pharmaceutical.